Mallia Therapeutics

Mallia Therapeutics Secures Funding For Hair Growth Drug CD83

July 11, 2023 /

The German biotech startup Mallia Therapeutics (formerly MalliaBiotech) has secured seed funding to further its hair loss drug soluble CD83. CD83 Hair Growth Through Immune Modulation On July 11, 2023, Mallia Therapeutics issued a press release announcing a successful seed financing round and the presentation of data at a European Hair Research Society (EHRS) meeting.…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.